In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Dr. Gay concluded his presentation discussing phase l results of a trial assessing radium-223, peposertib, and avelumab in advanced mCRPC with the following take home points: The combination of radium ...

The analysis by Ontada tracked testing rates within the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 ...

"The completion of this Phase 2a study is a significant milestone for Vaximm AG, as it provides strong evidence that VXM01, in combination with avelumab ... an oral T-cell immunotherapy that ...

If they do not experience disease progression after 4-6 cycles of first-line platinum-based chemotherapy (PBC), they may benefit from immunotherapy as maintenance treatment with Avelumab; otherwise, ...

“All drugs have side effects, but most people on immunotherapy have minimal side effects ... Transcript has been edited for clarity and conciseness. Avelumab first-line maintenance therapy in advanced ...

Avelumab is described as a human anti-programmed death ligand ... the company has announced positive Phase I and preliminary Phase II data from the trial at the Society for Immunotherapy of Cancer ...

Bavencio (avelumab) is a prescription drug used to ... Bavencio is a type of immunotherapy. The way it works (also called its mechanism of action) is by strengthening your immune system.

Immune checkpoint inhibitors help release these brakes. Three ICIs have been approved for MCC patients: pembrolizumab, avelumab and retifanlimab. “Immunotherapy has been a big revolution, but there ...